Objective measures, namely, limb discrepancy and its pre- and postoperative difference; laboratory infection makers (CRP, WBC, ESR, and liver and kidney function) and their alterations; and ASAMI (bone and functional), clinical (weight-bearing ability), and radiographic evaluation of fracture healing will be also assessed according to a preformed timetable (Table 2). This evidence concerns the gene CRP and infection.